Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Double-Blind Trial of Bepanthen® Cream Versus Cetomacrogol Cream in the Prevention of Papulopustular Eruption in Patients Receiving Epidermal Growth Factor Receptor Inhibitors (EGFRI): BeCet

NCT01136005 is registered in ClinicalTrials.gov with Impaqtt Foundation as lead sponsor.

NCT NCT01136005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01136005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Double-Blind Trial of Bepanthen® Cream Versus Cetomacrogol Cream in the Prevention of Papulopustular Eruption in Patients Receiving Epidermal Growth Factor Receptor Inhibitors (EGFRI): BeCet
Lead sponsor
Impaqtt Foundation
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
March 31, 2017
Enrollment
160 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, skin rash